We recently published a list of the 11 Most Promising Small-Cap Stocks According to Analysts. In this article, we are going ...

The company anticipates submitting a biologics licence application for accelerated approval in the US in early 2026.

This year's Futures National Conference, hosted by CureDuchenne for the Duchenne and Becker MD communities, is scheduled to ...

Dyne anticipates filing a Biologics License Application (BLA) submission for US accelerated approval in early 2026.

President Donald Trump told NBC News in an interview Saturday that he would not fire anyone involved in the Signal group chat in which military attack plans were inadvertently divulged to a ...

Explore GISTs, rare GI tumors. Discover key details on genetic causes, diagnostic methods, and cutting-edge treatment ...

It's been nearly two years since Elevidys, a gene therapy for Duchenne MD developed by Sarepta Therapeutics, was approved by ...

John Brandsema, MD, a pediatric neurologist at Children’s Hospital of Philadelphia, speaks with Healio about the current understanding of the genetic factors behind muscular dystrophy.